Connect with us

CSE / TSX

Organigram Holdings Inc (CVE:OGI) Registers 25% Patient Growth In The Third Quarter

Published

on

organigram-holdings-inc

Organigram Holdings Inc (CVE:OGI) posted the financial report for the quarter closing May 31, 2017. The quarterly results included expenses linked with the implementation of the “QA Program”. This program was followed to ensure that the firm manufactures the best quality product available in the market and in anticipation to a previously reported voluntary recall of certain items produced last year.

The details

As a result of Organigram Holdings’ increased focus on product safety and quality with the planned objective of establishing a pioneering role in such regard within the marketplace, the firm focused on launching product of the top quality to the market. This program effectively noted product lots that had to be eliminated from inventory well before being launched to the market. The successful implementation of QA program led in a decline in inventory value for the third quarter.

Organigram is delighted with the results and development recorded during the third quarter from an operational view and management is assured that these measures establish the base for long-term success for the firm. This focus on product quality led to a 25% net jump in registered patients in the third quarter as compared to the second quarter of this year.

In addition, the firm continued to make notable headway in increasing its production capacity and confirming that it is all set to be a market pioneer in the proposed adult-use recreational industry in anticipation of a June 2018 adult recreational program release date.

Greg Engel, the CEO of Organigram, reported that their top priority in the third quarter was ensuring that product safety and quality remain a stated goal of company. Through the application of a tier-one quality assurance plan and better production techniques, the firm will ensure that just the top quality product is offered to clients of Organigram. Engel added that they are assured that these actions lead in company being well set for future success.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement